Back to Trials
NCT06841861PHASE1, PHASE2RecruitingAccepts Healthy Volunteers

Spermatogonial Differentiation Via Testicular Organoid

CellARTs Inc.

Start Date

3/28/2024

Completion Date

1/1/2027

Summary

Purpose: This clinical trial aims to explore the potential for human sperm production in vitro by sustaining a laboratory-cultured adult testicular environment. It also seeks to identify genetic factors contributing to human sterility and failed spermatogenesis. The study's primary objectives include: 1. Identifying genomic markers associated with sterility and failed spermatogenesis. 2. Developing an ex vivo (outside the body) testis "organ-on-a-chip" ("iTestis") to support stem cell cultivation. 3. Determining whether human spermatogenesis can be re-created in vitro using stem cells nurtured in the iTestis model. Study Description: Researchers will analyze the genomic profiles of fertile and sterile male participants to map genetic abnormalities associated with sterility. Using testicular and skin tissue samples from participants, spermatogonial stem cells and pluripotent stem cells will be isolated and utilized to construct the ex vivo iTestis. This system will integrate genomic insights and prior research to foster human spermatogenesis outside the body. Participant Involvement: Participants will provide the following samples: * Blood sample for serum analysis. * A skin tissue biopsy. * Testicular tissue, obtained through fine needle aspiration (FNA) or testicular sperm extraction (TESE), as part of a routine procedure. All procedures will be conducted by the principal investigator and qualified research staff, ensuring participant safety and adherence to ethical guidelines.

Eligibility Criteria

Age Range: 18 years to 60 years

Inclusion Criteria: Group 1 (Fertile Control) * Male sex of reproductive age (between 18 - 60 years old). * Evidence of fertility or normal spermatogenesis. * Will undergo study procedures in conjunction with their planned fertility or infertility procedures performed for clinical purposes. Inclusion Criteria: Group 2 and 3 (Infertile) * Male sex of reproductive age (between 18 - 60 years old). * Males with evidence of \>1 year of infertility. * Posesses diagnosis of azoospermia is on clinical evaluation. * Will undergo study procedures in conjunction with their planned fertility or infertility procedures performed for clinical purposes. Exclusion Criteria: \- The lack of diagnosis of fertility or infertility, and lack of testicles.

Interventions

GENETIC

Stem cell

GENETIC

Genetic Screening

GENETIC

Genetic Reprogramming

GENETIC

Cell Maturation

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Infertility, MaleGene AbnormalitySterility, Male

Locations

The Turek Clinic

San Francisco, California 94108

United States